CMPS News and Press, COMPASS Pathways Plc From 11/13/23

The United States Department of Veteran Affairs (VA) has expressed that it is willing to consider the use of psychedelics in post-traumatic stress disorder (PTSD) treatment. In a statement issued to KDKA-TV Investigates, the agency said that it is open to the use of hallucinogenics to treat PTS...

Researchers have found that there may be a “clear association” between psychedelic use and embracing alternative viewpoints. Intent on determining whether exposure to psychedelics made people more likely to affirm alternative views, the research team provided a Conspiracy Mentality...

2023-11-05 01:03:52 ET Summary In August 2023 COMPASS Pathways announced a major private placement that initially eased concerns regarding the group’s cash runway. A sharp fall in the COMPASS Pathways share price since mid-September 2023 has put the majority of the private ...

2023-11-04 11:51:04 ET COMPASS Pathways plc (CMPS) Q3 2023 Results Conference Call November 02, 2023 08:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Mary-Rose Hughes - Interim CFO Dr. Guy Goodwin - Chief Medical Officer Confe...

2023-11-03 11:39:36 ET Image source: The Motley Fool. Compass Pathways Plc (NASDAQ: CMPS) Q3 2023 Earnings Call Nov 02, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Compass Pathways Plc (CMPS) Q3 2023 Earnings Call Tr...

2023-11-02 08:09:11 ET More on COMPASS Pathways ADS Compass Pathways: Debt Deal Secured, Cash Runway Extended COMPASS Pathways plc (CMPS) Q2 2023 Earnings Call Transcript Psychedelics research amendments advance in House committee With ecstasy a potential PTS...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2023 and provided an ...

COMPASS Pathways Plc (CMPS) is expected to report $-0.5 for Q3 2023

Researchers from Sorbonne University have found that ketamine can reduce depression symptoms in patients with treatment-resistant depression (TRD) just four hours after infusion. Compared to healthy controls, patients with TRD reported feeling more optimistic a few hours after ketamine infusion...